Maintenance of normal function of cells and tissues is dependent on precise regulation of multiple signaling pathways that control cellular decisions to either proliferate, differentiate, arrest cell growth, or initiate programmed cell death.
8 greater than 2-fold the background value. Three macroarrays were performed for MN2 control clone and the values for each gene were averaged.
Enzyme activities -γ-GCS was assayed as described by Seelig and Meister (33) . Cell pellet was lysed in 0.1 M TRIS-HCl, pH 8 containing 5 mM MgCl2 and 2 mM DTT, centrifuged at 12,550 × g for 30 min. Supernantants were used for γ-GCS determination following the oxidation of NADH at 340 nm in 0.1 M TRIS-HCl, pH 8 containing 150 mM KCl, 5 mM Na 2 -ATP, 2 mM phospho-enolpyruvate, 10 mM L-glutamate, 10 mM L-α-aminobutirate, 20 mM MgCl 2 , 2 mM Na 2 -EDTA, 0.2 mM NADH and 17µg pyruvate kinase/lactate dehydrogenase. Data were expressed as nmoles of NADH oxidized/mg prot. GSSG-reductase activity was monitored spectrophotometrically as previously described (34) by following the changes in absorbance at 340 nm due to the oxidation of NADPH using as substrates 0.17 mM NADPH and 2.2 mM GSSG in 100 mM phosphate buffer 0.5 mM EDTA, pH 7.2 at 37 °C Data were expressed as nmoles of NADPH oxidized/mg prot.
Statistical analysis.
The results are presented as means ± S.D. Significant changes were assessed by the Student's t test for unpaired data, and p values < 0.05 were considered significant. 
RESULTS

Apoptosis mediated by down-regulation of c-Myc is associated with cell depletion of GSH -
Two M14 melanoma transfectants (MAS51 and MAS53) expressing 6-10 times lower cMyc protein than control clone (MN2) and M14 parental line (23) were employed. By means of the annexin V versus PI staining assay (Fig. 1A) , we demonstrated that MAS51 and MAS53 clones showed spontaneous apoptosis, which increased from about 6% at day 2 to about 40% at day 6. On the contrary, no apoptosis was observed in both control lines for as long as 6th days of growth. At day 4 of growth, when about 15% of apoptosis was evident in both MAS51 and MAS53 transfectants, the values of GSH were significantly lower (p<0.01) than both M14 and MN2 control cells, with a concomitant significant increase (p<0.05) in the GSSG form of the tripeptide, while mixed disulfides between glutathione and cysteine residues of proteins were undetectable (Fig. 1B) . Fig. 2A shows that GSH content was significantly different as early as 2 and 3 days of growth (*p < 0.05, **p < 0.01) far ahead of time when the apoptotic process was committed, indicating that its decrease represents an upstream event in the induction of apoptosis.
The steady state level of GSH in the cell results from a balance between the rates of synthesis and loss of the tripeptide via oxidation or excretion. Under our experimental conditions we detected an increase in intracellular GSSG content as early as at 2 days of growth ( Fig. 2B ) that is commonly observed when cells are oxidatively stressed. This evidence could, at least in part, be explanatory for the lower levels of GSH present in MAS51 and MAS53 clones; on the other hand, a significant increase in GSH content was determined in the culture media of these clones (Fig. 2C) at day 3 and 4 of growth (p<0.01and p<0.001 respectively).
Down-regulation of c-Myc reduces γ-GCS and GSSG-reductase expression and activity
levels-In search of a mechanism responsible for the early alterations observed in GSH content following down-regulation of c-Myc, we monitored two key enzymes determining the balance of glutathione forms in the cells: γ-GCS, which is the rate-limiting enzyme in GSH synthesis, and the NADPH-dependent GSSG-reductase, which is responsible for efficient back reduction of GSSG to GSH. Fig. 3 reports the activity (A) and protein (B) levels of γ-GCS. The results show a significant decrease in the activity (about 40%) as early as at 2 days of growth, with no further decrement in both MAS51 and MAS53 transfectants when compared to MN2 and M14 parental line. These data are in line with the protein concentration of the two subunits of the synthetase, the heavy catalytic (γ-GCS H ) and the light regulatory (γ-GCS L ), as assayed by Western blot analysis (Fig. 3B) .
Similarly, the activity of GSSG reductase showed a significant decrease in both the clones expressing low c-Myc (Fig. 3C) , thus well correlating with the changes in the GSSG content observed in MAS51 and MAS53 transfectants, as compared to control lines.
Dependence of gene expression profiles on c-Myc was analyzed by macroarray technology (Fig. 4) . The figure shows that many genes are down-regulated in the clones expressing low c-Myc with respect to control, including c-myc itself and many genes already known as targets of c-Myc. In particular, down-regulation of c-Myc induced a significant reduction of genes of enzymes related to the metabolism of glutahione: γ-GCS, NADPH-dependent GSSG-reductase, glutathione S transferase-µ1, -θ1, -A1 and microsomal glutathione S transferase II. (Fig. 5C ). On the contrary, cytochrome c release from mitochondria was detectable as early as at 2 days of growth (Fig. 5D ). The release was concomitant to decrease of GSH and preceded the surface exposure of phosphotidilserine, as specifically detected by annexin V staining (see Fig. 1A ).
Down-regulation of c-Myc commits M14 melanoma cells to apoptosis
Activation of apoptosis in the clones expressing low amount of c-Myc depends on GSH -
When NAC (5mM), which is known to support GSH synthesis, or GSH ester (5mM), were added to transfectants with low c-Myc at day 1 of growth and left in the medium for the following 24 hrs, the intracellular GSH content, was increased to levels as high as those assayed in M14 cells, at day 2 of growth ( Fig. 6A ). This effect was maintained for the following days of growth (data not shown) and caused a reduction of apoptosis (Fig. 6B ).
The reverting ability of NAC and GSH ester was not due to increased expression of c-myc (Fig. 6C ). As soon as the GSH concentration rose following both treatments, cytochrome c was not efficiently accumulated in the cytosol (Fig. 6D) . Although both treatments partially reverted the induction of apoptosis in both clones with low c-Myc, the NAC treatment only was able to completely abolish the intracellular ROS production, while the administration of GSH ester reduced it by about 50%. The activities of caspase-9 and caspase-3 were significantly reduced following NAC or GSH ester treatment, being the proteolytic activity less than 10%.
Transient down regulation of c-Myc induces apoptosis through decrease of GSH -In order
to ascertain that the cell depletion of GSH and the induction of the apoptotic program were actually specific events of down-regulation of c-Myc, we generated M14 doxycyclineinducible clones (named MAS IND 1 and MAS IND 18). Both clones, following doxycycline administration, showed a reduction in the protein levels of c-Myc (50-60 %) (Fig. 7A ) and a concomitant decrease of GSH content (Fig. 7B) . Moreover, a time dependent increase in the percentage of annexin V+ cells was detected starting from 24 h after doxycycline treatment (Fig. 7B ). Subsequent to cell depletion of glutathione, cytochrome c was released from mitochondria, leading to the induction of the downstream events of apoptotis, such as production of ROS and activation of caspase-9 and -3 (data not shown).
DISCUSSION
The biological effects of c-Myc are clearly due to its ability to both positively and negatively affect gene transcription. Current evidence is in agreement with the notion that deregulation of cell growth and proliferation is critically affected in c-Myc-related tumorigenesis. It is also clear that c-Myc controls or affects other processes that may be highly relevant for its tumorigenic action.
In the present report we demonstrate that down-regulation of c-Myc commits melanoma cells to apoptosis via alteration of GSH balance in the cell at two key points: GSH biosynthesis and GSH regeneration from GSSG reduction. In fact, by using stable and The observed unbalance in the redox equilibrium of GSH was due to down-regulation of two key enzymes of glutathione metabolism, along with changes observed in other gene transcription, that, as expected, are more related to cell cycle regulators (40) . In this context, it should be reminded that another gene involved in the redox regulation has been recently reported to be a target of c-Myc, i.e. PRDX3, encoding a mitochondrial protein of the peroxiredoxin family (41) . As far as γ-GCS and NADPH-dependent GSSG reductase enzyme regulation is concerned, there are no data demonstrating a direct transcriptional regulation of γ-GCS and GSSG-reductase genes by c-Myc. Anyway, the results obtained with transient down-regulation of c-Myc (Fig. 7 ) strongly favor this hypothesis. A rapid decrease of intracellular GSH following deregulation of GSH biosynthesis has been recently demonstrated, as result of cleavage of the catalytic subunit of γ-GCS by caspase-3 during apoptotic cell death (42) . However, under our experimental conditions, the activation of caspase-3 was significant only after 6 days of growth, while a decrement in both protein and activity levels of γ-GCS was already detectable after 2 days of growth, thus indicating that they are probably due to a direct consequence of down regulation of cMyc. Moreover, the reduction of intracellular GSH content is aggravated by efficient extrusion of GSH, already observed at 2 days of growth, before the execution of apoptosis.
These results are in agreement with previous data demonstrating that cells, stimulated to undergo apoptosis, get rid of their GSH in order to allow apoptosis to take place (30).
However, we previously found that GSH loss may be necessary but not sufficient for triggering apoptosis, since lowering the GSH content of the cell by BSO and DEM we were not able to induce apoptosis in U937 or HepG2 cells (30). This discrepancy may depend on cell context or on the modality by which GSH is lost: some cell types might slowly adapt to a situation of GSH deprivation by setting up other ways of maintaining a correct redox equilibrium, while other types, including melanoma, are particularly sensitive to depletion of GSH (43, 44) . In our experimental model, the decrease of GSH is strictly associated to apoptosis, since supplementation with NAC or with GSH ester is able to abrogate apoptosis.
Cell depletion of GSH caused by down-regulation of c-Myc is closely linked to mitochondria dysfunction. In fact, we evidenced that release of cytochrome c from the mitochondria to the cytosol was concomitant to the decrease of GSH. These results are consistent with our previous data demonstrating that a diminution of intracellular GSH content obtained either by chemical inhibition of its neosynthesis or by eliciting the extrusion of GSH, causes cytochrome c release from mitochondria (31) . However, we previously demonstrated that cytochrome c release is a cellular response to lack of GSH and it can occur even in the absence of cell commitment to apoptosis: thus, cytochrome c release per se is not sufficient to trigger apoptosis, but other events have to occur (31) . In our model, cytochrome c release is an early event and it is followed by ROS production and proteolytic activation of caspases -9 and -3. The increased ROS production in cells deprived of GSH can be ascribed to an alteration of the redox equilibrium following the impairment of systems able to scavenge or detoxify the various reactive oxygen intermediates generated by normal cell metabolism.
In summary, in this study we outline the mechanisms by which down-regulation of c-Myc commits melanoma cells to apoptosis. In particular, we demonstrate that inhibition of the expression of c-myc causes deregulation of the biosynthesis of GSH and of the GSH/GSSG ratio. Decrease of GSH and consequent cytochrome c release are early events in the apoptotic process since they precede the surface exposure of phosphatidylserine. On the contrary, ROS production and activation of caspase-9 and -3, occurring later in the apoptotic process, appear as consequences of redox unbalance. On the basis of these results, γ-GCS and GSSG reductase appear as possible therapeutic targets that can be specifically modulated to re-establish the apoptotic pathway in cancer cells. Moreover, since elevated levels of GSH have also been reported to play an important role in mediating tumor cell resistance to chemotherapy, the effect of downregulation of c-Myc on GSH may contribute to increase drug susceptibility. 
